Order Article Reprints

Uwamahoro H, Collier WE, Nashar TO, Jaynes JM, Mortley DG, Davis CG, Kanyairita GG, Abdelazim EF, Igiramaboko JFR, Habineza C, et al. Natural and Designed Cyclic Peptides as Potential Antiviral Drugs to Combat Future Coronavirus Outbreaks. Molecules. 2025; 30(8):1651. https://doi.org/10.3390/molecules30081651

Uwamahoro, Hilarie, Willard E. Collier, Toufic O. Nashar, Jesse M. Jaynes, Desmond G. Mortley, Cheryl G. Davis, Getrude G. Kanyairita, Eslam F. Abdelazim, Jean Francois Regis Igiramaboko, Concorde Habineza, and et al. 2025. "Natural and Designed Cyclic Peptides as Potential Antiviral Drugs to Combat Future Coronavirus Outbreaks" Molecules 30, no. 8: 1651. https://doi.org/10.3390/molecules30081651

Uwamahoro, H., Collier, W. E., Nashar, T. O., Jaynes, J. M., Mortley, D. G., Davis, C. G., Kanyairita, G. G., Abdelazim, E. F., Igiramaboko, J. F. R., Habineza, C., Tumushimiyimana, D., Rutayisire, U. N., Davis, Y. A., & Renard, K. L. (2025). Natural and Designed Cyclic Peptides as Potential Antiviral Drugs to Combat Future Coronavirus Outbreaks. Molecules, 30(8), 1651. https://doi.org/10.3390/molecules30081651